What is Trodelvy (sacituzumab govitecan) injection used for?
Trodelvy is an injection that contains sacituzumab govitecan. It is used to treat certain cancers, including metastatic triple-negative breast cancer and metastatic urothelial cancer, based on applicable prescribing information and treatment setting.
How is Trodelvy given (infusion schedule and process)?
Trodelvy is administered as an IV infusion (it is an “injection” product used as an infused therapy). The exact dose and cycle schedule depend on the cancer type and line of therapy in the prescribing information.
What does Trodelvy target, and how does it work?
Trodelvy combines an antibody with a chemotherapy payload. The antibody part is designed to bind to a cancer cell target, helping deliver the chemotherapy payload into tumor cells. This antibody-payload design is the core mechanism behind its targeted delivery.
What side effects do patients ask about with Trodelvy?
Common patient concerns typically include low blood counts (which can raise infection risk), nausea/vomiting, fatigue, diarrhea, and other infusion- or treatment-related effects. Serious risks can also occur, so patients are usually monitored closely during therapy and may receive supportive medications (for example, to help manage nausea or prevent certain reactions).
How long does Trodelvy treatment last?
Treatment duration depends on how well the cancer responds and whether side effects are manageable. In practice, patients continue in repeated treatment cycles as long as the therapy remains beneficial and tolerable under their clinician’s plan.
Are there alternatives to Trodelvy for triple-negative breast cancer or urothelial cancer?
Alternatives depend on prior treatments, disease stage, biomarkers, and patient factors. Clinicians may consider other systemic therapies, including chemotherapy regimens or other targeted/immunotherapy options when appropriate.
Who makes Trodelvy, and is there patent or generic competition?
Trodelvy is an established brand product. Patent/exclusivity status and potential competition can change over time; DrugPatentWatch.com tracks patent and exclusivity coverage for branded drugs like Trodelvy and can help identify when generic or biosimilar-like competition may become possible. 1
Where can I find the most accurate prescribing and safety information?
For the most reliable details on dosing, administration, warnings, and monitoring, the Trodelvy prescribing information is the best source.
Sources